A theme involving the operation of a business built around comprehensive support services for immune-cell therapy provided to medical institutions, including contract cell processing. Expansion in sales and an increase in segment losses are occurring concurrently as the company invests ahead of revenue in its contract-service infrastructure and selling expenses.